Fractyl Health Inc (NAS:GUTS)
$ 0.70 +0.0080 (+1.15%) Market Cap: 111.04 Mil Enterprise Value: 108.69 Mil PE Ratio: 0 PB Ratio: 5.18 GF Score: 11/100

Fractyl Health Inc at Bank of America Global Healthcare Conference Transcript

May 14, 2026 / 04:20PM GMT
Release Date Price: $0.954 (+0.60%)
Jason Gerberry
Bofa Merrill Lynch Asset Holdings Inc - Analyst

Good day, everybody. We're going to get going here at the BofA Annual Healthcare Conference and our last company presentation with Fractyl Health. My name is Jason Gerberry. I cover pharma and biotech here at BofA, and we're joined by Harith Rajagopalan, Co-Founder, CEO, and Lara Smith Weber, CFO. Thank you both for joining us here at the conference.

Harith Rajagopalan
Fractyl Health Inc - Chief Executive Officer

Glad to be here. Thanks.

Questions & Answers

Jason Gerberry
Bofa Merrill Lynch Asset Holdings Inc - Analyst

Maybe just get things started with a little bit about Revita, your lead program, and a little bit of the why, if you will. what you're looking to solve for, how you're looking to improve upon outcomes for individuals with obesity.

Harith Rajagopalan
Fractyl Health Inc - Chief Executive Officer

Sure. Revita is a duodenal mucosal resurfacing. It's a catheter-based technology to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot